Kaplan-Meier curves with a log-rank test revealed that ESCC patients with high METTL3 expression exhibited a worse prognosis and shorter survival time compared with that with low METTL3 expression (Figure 1F). This evidence concerns the gene METTL3 and esophageal squamous cell carcinoma.